Grifols SA Issues Inside Information
Ticker: GIKLY · Form: 6-K · Filed: Jul 8, 2024 · CIK: 1438569
| Field | Detail |
|---|---|
| Company | Grifols SA (GIKLY) |
| Form Type | 6-K |
| Filed Date | Jul 8, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: inside-information, disclosure, foreign-private-issuer
TL;DR
Grifols dropped a 6-K with 'inside info' on July 8th - watch this space.
AI Summary
Grifols, S.A. has issued inside information on July 8, 2024, regarding news published concerning the company. The filing is a Form 6-K, which is a report of a foreign private issuer. Grifols is a pharmaceutical preparations company based in Barcelona, Spain.
Why It Matters
This filing indicates Grifols is disclosing material non-public information, which could impact investor decisions and stock price.
Risk Assessment
Risk Level: medium — The disclosure of 'inside information' suggests potential material events that could affect the company's valuation.
Key Players & Entities
- Grifols, S.A. (company) — Registrant
- July 8, 2024 (date) — Date of Inside Information
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What specific news is Grifols, S.A. referring to in its inside information disclosure?
The filing states that Grifols, S.A. is informing about inside information 'With respect to the news published' but does not specify the exact news within this document.
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of a foreign private issuer required to be filed with the SEC to provide information that the company has made or is required to make public in its home country.
When was the inside information dated?
The inside information is dated July 8, 2024.
Where is Grifols, S.A. headquartered?
Grifols, S.A. is headquartered in Sant Cugat del Vallès, Barcelona, Spain.
What is Grifols, S.A.'s Standard Industrial Classification code?
Grifols, S.A.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 419 words · 2 min read · ~1 pages · Grade level 9.4 · Accepted 2024-07-08 13:56:28
Filing Documents
- tm2419037d1_6k.htm (6-K) — 15KB
- tm2419037d1d1_6k1img001.jpg (GRAPHIC) — 17KB
- 0001104659-24-078269.txt ( ) — 40KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. Grifols, S.A. By: /s/ David I. Bell Name: David I. Bell Title: Authorized Signatory Date: July 8, 2024